Rachel Haurwitz Ph.D.
Net Worth

Last updated:

What is Rachel Haurwitz Ph.D. net worth?

The estimated net worth of Ms. Rachel Haurwitz Ph.D. is at least $2,010,660 as of 8 Sep 2025. She has received compensation worth at least $2,010,660 in Intellia Therapeutics, Inc. and Caribou Biosciences, Inc..

What is the salary of Rachel Haurwitz Ph.D.?

Ms. Rachel Haurwitz Ph.D. salary is $670,220 per year as Co-Founder, Chief Executive Officer, Pres & Director in Caribou Biosciences, Inc..

Rachel Haurwitz Ph.D. insider trading

Caribou Biosciences, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 10,000 $2.96 $29,600
Option
Option to purchase Common Stock 10,000 $2.96 $29,600
Option
Option to purchase Common Stock 10,000 $2.96 $29,600
Option
Common Stock 10,000 $2.96 $29,600
Option
Common Stock 10,000 $2.96 $29,600
Option
Option to purchase Common Stock 10,000 $2.96 $29,600
Option
Option to purchase Common Stock 10,000 $2.96 $29,600
Option
Common Stock 10,000 $2.96 $29,600

Intellia Therapeutics key executives

Intellia Therapeutics, Inc. executives and other stock owners filed with the SEC:

  • Dr. Andrew D. Schiermeier (55) Executive Vice President & Chief Operating Officer
  • Dr. Derrick J. Rossi Founder & Member of Scientific Advisor Board
  • Dr. Jennifer A. Doudna Founder & Member of Scientific Advisor Board
  • Dr. John M. Leonard (68) Pres, Chief Executive Officer & Director
  • Dr. Laura Sepp-Lorenzino (64) Executive Vice President & Chief Scientific Officer
  • Mr. Andrew May Ph.D. Founder and Member of Scientific Advisor Board
  • Mr. Glenn G. Goddard (54) Executive Vice President & Chief Financial Officer
  • Mr. José E. Rivera (59) Executive Vice President, Gen. Counsel & Company Sec.
  • Mr. Nessan Bermingham Ph.D. Founder & Member of Scientific Advisor Board
  • Ms. Rachel Haurwitz Ph.D. Co-Founder